HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hironori Teramoto Selected Research

N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)

11/2021Interruption of endolysosomal trafficking leads to stroke brain injury.
1/2021Interruption of Endolysosomal Trafficking After Focal Brain Ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hironori Teramoto Research Topics

Disease

2Brain Ischemia (Cerebral Ischemia)
11/2021 - 01/2021
1Brain Injuries (Brain Injury)
01/2021
1Soft Tissue Infections
01/2017

Drug/Important Bio-Agent (IBA)

2N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)IBA
11/2021 - 01/2021
1salicylhydroxamic acid (SHAM)IBA
11/2021
1CathepsinsIBA
11/2021
1Soluble N-Ethylmaleimide-Sensitive Factor Attachment ProteinsIBA
01/2021
1HydrolasesIBA
01/2021
1SNARE Proteins (SNAREs)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Methicillin (Metin)FDA Link
01/2017

Therapy/Procedure

1Therapeutics
01/2017